Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 280
Selected: 0
NCT IDTitle
NCT03617133Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer
NCT00370240Chlorhydrate of Ropivacaine and Breast Cancer Surgery
NCT00126269Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
NCT01486251Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer
NCT02856425Trial Of Pembrolizumab And Nintedanib
NCT01884922Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults
NCT05705791Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NCT06022341MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies
NCT01706016Local Treatment by Thermic Destruction of Primitive Breast Cancer
NCT02992912Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours
NCT00180791High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
NCT02666690Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast
NCT02523612Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions
NCT07016230Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
NCT00410683Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery
NCT01801176Peripheral Primitive Fibromatosis
NCT01371201First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma
NCT00127049Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
NCT02230176Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II
NCT00181025Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
NCT04842162Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery
NCT04224389IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
NCT03613194Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer
NCT06642844Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
NCT01167530Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer
NCT02679963Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
NCT02813135European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
NCT04304924Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer
NCT04953312Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)
NCT04826198Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months
NCT02390934Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
NCT05691608MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
NCT04477681Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
NCT01516567Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation
NCT04932525Gustave Roussy Cancer Profiling
NCT03356535Metabolic Signature of Healthy Lifestyle and HCC
NCT06514235Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)
NCT06508216A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
NCT01159288Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes
NCT00634777Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma
NCT00126230Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer
NCT02997384Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT02666625Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank
NCT02619565Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes
NCT03323424Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers
NCT02246244Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress
NCT05692999Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
NCT00552149Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
NCT00544349Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
NCT00435851Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients